| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,954 |
6,098 |
$198K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,536 |
5,680 |
$187K |
| 95943 |
|
418 |
373 |
$35K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,718 |
2,631 |
$33K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,413 |
1,079 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
867 |
742 |
$13K |
| 80305 |
|
1,843 |
1,693 |
$12K |
| 95923 |
|
379 |
343 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,440 |
691 |
$11K |
| 95816 |
|
145 |
54 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
187 |
168 |
$6K |
| 96112 |
|
130 |
54 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
813 |
624 |
$6K |
| 96132 |
|
113 |
93 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
61 |
60 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
409 |
352 |
$4K |
| 99497 |
|
122 |
114 |
$3K |
| 86328 |
|
133 |
113 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
45 |
43 |
$2K |
| 93922 |
|
93 |
80 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
58 |
55 |
$2K |
| 82947 |
|
636 |
529 |
$1K |
| 96138 |
|
110 |
92 |
$1K |
| 99307 |
|
172 |
145 |
$1K |
| 95957 |
|
14 |
13 |
$921.20 |
| 99408 |
|
168 |
161 |
$843.26 |
| 90756 |
|
66 |
56 |
$834.96 |
| 96127 |
|
426 |
381 |
$721.85 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
66 |
63 |
$717.60 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
14 |
14 |
$699.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
159 |
117 |
$684.11 |
| 86318 |
|
76 |
67 |
$592.69 |
| 99407 |
|
40 |
36 |
$576.00 |
| 36416 |
|
961 |
794 |
$339.69 |
| 94760 |
|
54 |
44 |
$287.60 |
| 87807 |
|
28 |
27 |
$273.88 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
31 |
29 |
$238.24 |
| 36415 |
Collection of venous blood by venipuncture |
350 |
320 |
$216.85 |
| 90630 |
|
16 |
15 |
$194.47 |
| 96103 |
|
88 |
79 |
$181.41 |
| G2011 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes |
140 |
130 |
$170.18 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
468 |
329 |
$106.17 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
947 |
719 |
$94.45 |
| 99401 |
|
17 |
15 |
$80.21 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
41 |
28 |
$38.48 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
43 |
41 |
$27.00 |